International Clinical Trial: Efficacy and Safety of Naoxueping in Non-Surgical Patients with Acute Intracerebral Hemorrhage

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126587) titled 'Efficacy and Safety of Naoxueping in Non-Surgical Patients with Acute Intracerebral Hemorrhage' on June 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Xuanwu Hospital, Capital Medical University

Condition: Intracerebral Hemorrhage

Intervention: Experimental group:On the basis of standard treatment, Naoxueping is additionally administered (1 dose per day, divided into morning and evening doses, approximately 100?mL each time, for a treatment course of 14?days).

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-24

Target Sample Size: Experime...